Basis of Presentation and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2017

Accounting Policies [Abstract]

Schedule of Revenue by Major Customers by Reporting Segments

The Company had major payors that contributed the following percentage of net revenue:

	For The Years Ended December 31,
	2017			2016
Payor A		14.1	%		14.4	%
Payor B		18.1	%		17.8	%
Payor C		11.1	%		12.3	%
Payor D		11.3	%		14.0	%

The Company had major payors that contributed to the following percentage of receivables before the allowance for doubtful accounts:

	As of December 31,
	2017			2016
Payor D		23.8	%		37.4	%
Payor E		30.5	%		47.1	%

Fair Value Measurements, Recurring and Nonrecurring

The carrying amounts and fair values of the Company’s financial instruments as of December 31, 2017 are presented below:

	Fair Value Measurements
	Level 1		Level 2		Level 3		Total
Assets
Money market accounts*	$	41,231,405	$	-	$	-	$	41,231,405
Marketable securities – certificates of deposit		1,057,090		-		-		1,057,090
Marketable securities – equity securities		86,005		-		-		86,005
Total	$	42,374,500	$	-	$		$	42,374,500

The carrying amounts and fair values of the Company’s financial instruments as of December 31, 2016 are presented below:

	Fair Value Measurements
	Level 1		Level 2		Level 3		Total
Assets
Money market accounts*	$	42,553,887	$	-	$	-	$	42,553,887
Marketable securities – certificates of deposit		1,051,807		-		-		1,051,807
Derivative asset (warrants)		-		-		5,338,886		5,338,886
Total	$	43,605,694	$	-	$	5,338,886	$	48,944,580

* Included in cash and cash equivalents

Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation

The following summarizes activity of Level 3 inputs measured on a recurring basis for the years ended December 31, 2017 and 2016:

	Derivative Assets (Warrants)
Balance at January 1, 2015	$	2,088,889
Fair value of warrants acquired in ApolloMed		1,527,776
Change in fair value of warrant liabilities		1,722,221
Balance at December 31, 2016		5,338,886
Change in fair value of warrant liabilities		(44,886)
Balance at Merger		5,294,000
Distribution to former NMM shareholders		(5,294,000)
Balance at December 31, 2017	$	-